Who should participate in this survey?

NSW Therapeutic Advisory Group (TAG), in conjunction with the QLD Drug Use Evaluation Subcommittee (DUESC), is conducting a survey in order to understand the current status of drug use evaluation (DUE) activities* within NSW, ACT and QLD public hospitals including the identification of barriers, enablers and resource allocation. The information will be used to inform a written report which will be made available on the NSW TAG website and may be used for advocacy of DUE-type activity within the healthcare system. 

Directors of Pharmacy or their nominated delegates are invited to complete the survey. Only one response per hospital is required; although, in order for responses to be comprehensive, information should be sought from relevant colleagues participating in DUE-type activities before formulating a response and completing the survey. (In order for your responses to be comprehensive, a list of survey questions is available on the NSW TAG website).

The survey contains 25 questions and should take no more than 30 minutes to complete. Responses may be saved and/or edited until the survey is submitted (provided the same computer/IP address is used).

The survey is open from 19 February 2020 to 25 March 2020.

Ethics approval has been granted by the St Vincent's Hospital Network HREC. Participation in the survey is deemed to be consent. However, you may change your mind and withdraw from the study at any stage. No identifiable information will be published. Your contact details are collected in case NSW TAG needs to check a survey response. The collated (non-identifiable) responses will be written in a report that will be found on the NSW TAG website. The results may also be presented at conference proceedings.

* DUE-type activities include those undertaking antimicrobial stewardship, opioid stewardship, anticoagulant stewardship activities and QUM/medicines-related auditing etc. 

For the purpose of this survey:
- the term "health district" refers to Local Health Districts (LHDs) or Speciality Networks in NSW and Hospital and Health Services (HHS) in QLD.
- Drug and Therapeutics Committees in NSW and Medicines Management Committees in QLD are multidisciplinary committees with a commitment to the overall governance of medicines management system in their health service organisation to ensure the judicious, safe, effective and cost-effective use of medicines.

T